PT - JOURNAL ARTICLE AU - Arash Ghodousi AU - Emanuele Borroni AU - Marta Peracchi AU - Giorgio Palù AU - Loredana Fallico AU - Mario Rassu AU - Vinicio Manfrin AU - Paola Mantegani AU - Vincenzina Monzillo AU - Riccardo Manganelli AU - Enrico Tortoli AU - Daniela Maria Cirillo TI - Genomic Analysis of Cardiac Surgery-Associated <em>Mycobacterium chimaera</em> Infections in Italy AID - 10.1101/2020.04.03.20049577 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.03.20049577 4099 - http://medrxiv.org/content/early/2020/04/07/2020.04.03.20049577.short 4100 - http://medrxiv.org/content/early/2020/04/07/2020.04.03.20049577.full AB - One hundred and twenty-two Mycobacterium chimaera strains isolated in Italy from cardiac surgery-related patients, cardiac surgery-unrelated patients and from heater-cooler units, were submitted to whole-genome sequencing and to subsequent SNP analysis. All but one strains isolated from cardiac surgery-related patients belonged to Subgroup 1.1 (19/23) or Subgroup 1.8 (3/23). Only 28 out of 79 strains isolated from heater-cooler units belonged to groupings other than 1.1 and 1.8. The strains isolated from cardiac surgery-unrelated patients were instead distributed across the phylogenetic tree. Our data, the first on isolates from Italy, are in agreement with a recent large genomic study suggesting a common source, represented by strains belonging to Subgroups 1.1 and 1.8, of cardiac surgery-related Mycobacterium chimaera infections. The strains belonging to groupings other than 1.1 and 1.8 isolated from heather-cooler units evidently resulted from contaminations at hospital level and had no share in the Mycobacterium chimaera outbreak. One Mycobacterium chimaera strain investigated in this study proved distant from every previously known Mycobacterium chimaera Groups (1, 2, 3 and 4) and we propose to assign to a novel group, named” Group 5”.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNONEAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are in the manuscript and the sequence data has been put into the NCBI sequence read archive